Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose atorvastatin in type 2 diabetes
IRCT201502226710N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Tabriz University of Medical Sciences. Started Nov 2014; status: completed.
02
Drugs
atorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201502226710N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201502226710N5.